Fresh back from the 25th session of the International Medical Device Regulators Forum (IMDRF) in March, the UK Medicines and Healthcare products Regulatory Agency hit the ground running in April to progress its ambitious regulatory system plans for Great Britain.
Government and policy schedules will be disrupted by the havoc of the UK’s 2024 general election, the date for which has yet to be nailed down. While the MHRA’s device Regulatory